Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/11/2010US7713514 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
05/11/2010US7713326 A particulate plant nutrient coated by the reactionproduct of a mixture comprising a diisocyanate and/or an epoxy resin, a sulfur-containing vegetable oil and a crosslinked thioacrylate ester; polythiourethanes; wear resistance; strength; encapsulation; water solubility; environmentally friendly
05/11/2010CA2598516C Benzisoxazole derivatives
05/11/2010CA2536544C 2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
05/11/2010CA2503663C Novel quinoxalinone derivatives
05/11/2010CA2488868C Controlled release formulation of lamotrigine
05/11/2010CA2470342C Ribavirin granulate for producing coated tablets
05/11/2010CA2468953C Taxane derivative crystal and method for preparing the same
05/11/2010CA2465697C Process for the preparation of (s)-naproxen 4-nitrooxybutyl ester
05/11/2010CA2462110C Phenyl-piperazine derivatives as serotonin reuptake inhibitors
05/11/2010CA2461958C Combination dosage form containing a cholesterol-lowering agent, a renin-angiotensin inhibitor, and aspirin
05/11/2010CA2456095C An improved process for the preparation of amorphous atorvastatin calcium salt (2:1)
05/11/2010CA2442448C Condom with an erectogenic composition
05/11/2010CA2438260C Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2428994C Improved ophthalmic and contact lens solutions containing forms of vitamin b
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2417709C Compositions and dosage forms for application in the oral cavity in the treatment of mykoses
05/11/2010CA2415532C Novel 4-phenyl substituted tetrahydroisoquinolines therapeutic use thereof
05/11/2010CA2413134C Quinazoline ditosylate salt compounds
05/11/2010CA2412968C Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2403871C Inhibition of angiogenesis and tumor growth
05/11/2010CA2403343C Process for the preparation of accelerated release formulations using compressed fluids
05/11/2010CA2400612C Oxy-and amino-substituted tetrahydrofuryl derivatives with antitumour activity
05/11/2010CA2392570C 4-pyrimidinyl-n-acyl-l-phenylalanines
05/11/2010CA2381205C Method for determining physiological effects of hemoglobin
05/11/2010CA2378603C Benzofuran derivatives
05/11/2010CA2362243C Cartridge for a liquid
05/11/2010CA2355651C Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
05/11/2010CA2341638C Use of a midkine inhibitor
05/11/2010CA2335105C Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
05/11/2010CA2326324C Nitrogen-containing heterocyclic compound
05/11/2010CA2318696C Triazepinones, process for their preparation and their therapeutic application
05/11/2010CA2272439C A process for the preparation of 13-cis-retinoic acid
05/11/2010CA2165297C Myeloid cell leukemia associated gene mcl-1
05/11/2010CA2122365C Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/07/2010CA2684853A1 Dietary supplement for promoting wellness and weight loss and methods of administering the same
05/06/2010WO2010051561A1 Compounds for the treatment of osteoporosis and cancers
05/06/2010WO2010051549A1 Pyrazolopyrimidine jak inhibitor compounds and methods
05/06/2010WO2010051544A2 Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
05/06/2010WO2010051541A2 Compositions containing delta-9-thc-amino acid esters and process of preparation
05/06/2010WO2010051532A1 Compositions and methods related to obstructive sleep apnea
05/06/2010WO2010051521A1 Cell therapy product for the treatment of hiv infection
05/06/2010WO2010051503A1 Azepino [4, 5-b] indoles and methods of use
05/06/2010WO2010051501A1 Pyrido (4,3-b) indoles containing rigid moieties
05/06/2010WO2010051498A1 Biotechnology relating to mammalian reproduction
05/06/2010WO2010051497A1 Filamin a binding anti-inflammatory and analgesic
05/06/2010WO2010051476A1 Filamin a-binding anti-inflammatory analgesic
05/06/2010WO2010051447A1 Sulfonamide containing compounds and uses thereof
05/06/2010WO2010051374A1 Analgesic that binds filamin a
05/06/2010WO2010051373A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/06/2010WO2010051372A1 Process for the preparation of chymase modulators
05/06/2010WO2010051353A1 S1p lyase inhibitors for the treatment of cerebral malaria
05/06/2010WO2010051349A1 S1p receptor agonists for the treatement of cerebral malaria
05/06/2010WO2010051348A1 Preservative system for emulsion-based therapeutic topical formulations
05/06/2010WO2010051296A1 Pharmaceutical compositions containing diacerein
05/06/2010WO2010051291A1 Besifloxacin ophthalmic composition for the treatment or control of infection
05/06/2010WO2010051245A1 Benzimidazole and aza-benzimidazole carboxamides
05/06/2010WO2010051238A1 Pyridazine carboxamide orexin receptor antagonists
05/06/2010WO2010051237A1 2,5-disubstituted phenyl carboxamide orexin receptor antagonists
05/06/2010WO2010051206A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
05/06/2010WO2010051204A2 Bcr-abl variants
05/06/2010WO2010051196A1 Novel substituted azabenzoxazoles
05/06/2010WO2010051188A1 P2x3, receptor antagonists for treatment of pain
05/06/2010WO2010051177A1 Triazole beta carboline derivatives as antidiabetic compounds
05/06/2010WO2010051129A2 New imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
05/06/2010WO2010051127A2 Hematopoietic protection against ionizing radiation using selective cyclin-dependent kinase 4/6 inhibitors
05/06/2010WO2010051120A1 Pet food composition comprising an antioxidant component
05/06/2010WO2010051085A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
05/06/2010WO2010051064A1 COMPOUNDS THAT INHIBIT NFκB ACTIVITY
05/06/2010WO2010051044A1 Unique dual-action therapeutics
05/06/2010WO2010051031A1 Heterobicyclic sphingosine 1-phosphate analogs
05/06/2010WO2010051030A1 Bicyclic aryl sphingosine 1-phosphate analogs
05/06/2010WO2010050955A1 Broad spectrum microbicidal and spermicidal compositions and methods
05/06/2010WO2010050889A1 Topical composition comprising a combination of at least two penetration enhancing agents
05/06/2010WO2010050802A2 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
05/06/2010WO2010050801A1 Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mrna
05/06/2010WO2010050783A2 Novel compound with spiro chiral carbon backbone, preparation method thereof, and pharmaceutical composition containing the same
05/06/2010WO2010050584A1 Method for selectively controlling function of helper t cell
05/06/2010WO2010050577A1 Cyclohexane derivative and pharmaceutical use thereof
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050468A1 Cephalosporin having catechol group
05/06/2010WO2010050461A1 Novel amide derivative and use thereof as medicine
05/06/2010WO2010050456A1 Piperidine compound having di- or tri-arylmethyl structure
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050436A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010WO2010050435A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
05/06/2010WO2010050423A1 Ondansetron-containing external drug composition
05/06/2010WO2010050422A1 Agent for treatment of diabetes
05/06/2010WO2010050413A1 Method for producing sophorose lipid
05/06/2010WO2010050211A1 Composition for local anesthesia
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
05/06/2010WO2010050178A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound
05/06/2010WO2010050168A1 Solid solution of valine, isoleucine and leucine, and method for producing same
05/06/2010WO2010049954A1 Fatty acids for use as a medicament
05/06/2010WO2010049946A2 Thyroid receptor ligands
05/06/2010WO2010049921A1 Disaccharides
05/06/2010WO2010049915A1 Poly-heteroaryl derivatives for the treatment of cancer
1 ... 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 ... 7860